CLINICAL_TRIALS trial_result · 2017-10-30

Clinical Trial Update: Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive [Phase 2]

Phase 2 dose-ranging study in treatment-naive adults with Type 2 diabetes mellitus sponsored by GlaxoSmithKline; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-10-30